Reversibility of Diffusion-Weighted Imaging Lesions in Patients With Ischemic Stroke in the WAKE-UP Trial
Lauranne Scheldeman(Vlaams Instituut voor Biotechnologie), Robin Lemmens(VIB-KU Leuven Center for Microbiology), Götz Thomalla(Universität Hamburg), Salvador Pedraza(Hospital Clínic de Barcelona), Bastian Cheng(Universität Hamburg), Jeroen Bertels(KU Leuven), Vincent Thijs(Florey Institute of Neuroscience and Mental Health), Keith W. Muir(University of Glasgow), Anke Wouters(Universität Hamburg), Norbert Nighoghossian(Université Claude Bernard Lyon 1), Martin Ebinger(Universität Hamburg), Christian Gerloff(Universität Hamburg), Jochen B. Fiebach(Pathodiagnostik Berlin), Matthias Endres(German Center for Neurodegenerative Diseases), Claus Z. Simonsen(Universität Hamburg), Patrick Dupont(KU Leuven)
Cited by 17
Related Papers
Global, regional, and national burden of Parkinson's disease, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016
|The Lancet Neurology|2018|2.8k
Global, regional, and national burden of migraine and tension-type headache, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016
|The Lancet Neurology|2018|2k
MRI-Guided Thrombolysis for Stroke with Unknown Time of Onset
|New England Journal of Medicine|2018|1.3k
Thrombolysis Guided by Perfusion Imaging up to 9 Hours after Onset of Stroke
|New England Journal of Medicine|2019|1k
Tenecteplase versus Alteplase before Thrombectomy for Ischemic Stroke
|New England Journal of Medicine|2018|856